
Bone is the most common site for zzso from solid tumors, and the majority of patients will develop bone zzso during the natural course of their zzso zzso are an effective treatment for preventing zzso events in patients with bone zzso and may preserve functional independence and quality of zzso Although several zzso have been investigated in patients with solid tumors, only zzso acid zzso is approved by the US Food and Drug Administration and the European zzso Agency for preventing zzso events in patients across a broad range of solid zzso In addition, zzso notably zzso prevent cancer zzso bone loss in breast and prostate cancer patients who are receiving zzso zzso It also has been demonstrated that zzso directly and indirectly zzso cancer cell growth in zzso and growth and zzso in animal model zzso These properties may produce clinically meaningful zzso In recent clinical studies in patients with cancer, zzso improved overall and prolonged zzso zzso zzso clinical trials in patients with solid tumors will provide further insight into the potential of zzso to prevent distant zzso and improve zzso 

